Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

NCT03531645 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasms of Female Genital Organs

Interventions

DRUG: Fulvestrant
DRUG: Abemaciclib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]